Please read and agree to the
terms and conditions
of this site.
I agree
Medical Technology
/tech
Clear filters and search
Format
photo
Tags
biotech
boston blog main
3
×
boston top stories
clinical trials
3
×
deals
3
×
life sciences
national blog main
boston
fda
480 biomedical
alirocumab
alnylam pharmaceuticals
amgen
arsenal medical
bayer
bob langer
chronic rhinosinusitis
covid-19
cronos group
drug delivery
evolocumab
genzyme
george whitesides
ginkgo bioworks
hyperammonemia
inclisiran
inflammation
investing
ipo
james collins
keros therapeutics
liver diseases
lyra therapeutics
medical device
mometasone furorate
national top stories
neurological diseases
new york
new york blog main
new york top stories
What
company
3
×
medicines
new
acquire
agreed
bacteria
billion
biology
biotech
bioworks
brings
called
cash
cholesterol
compound
comprised
deal
debut
developer
developing
drug
engineered
fda
ginkgo
ipo
lands
late
living
lyra
markets
medco
million
nose
noses
novartis
persistently
poised
public
raised
raises
Language
unset
Current search:
company
×
deals
×
" clinical trials "
×
" boston blog main "
×
@xconomy.com
4 years ago
Lyra Therapeutics IPO Raises $56M for Tests of Tech for Runny Noses
@xconomy.com
4 years ago
Novartis to Acquire MedCo and FDA-Ready Cholesterol Drug for $9.7B
@xconomy.com
4 years ago
Synlogic Lands $80M from Ginkgo to Ramp Up “Living Medicines” R&D
